loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of chemical intermediates, fine chemicals supplied/manufactured by Zhejiang Huahai Pharmaceutical

    Client Virtual Booth
    Menu

    Zhejiang Huahai Pharmaceutical

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    INTERMEDIATES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Send me more info on How To Grow My Business Digitally?

    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 (3S,4R)-3-hydroxymethyl-4-(4'-fluorophenyl)-N-methylpiperidine (1)

    02 (3S,4R)-4-(4-fluorophenyl)-3-(3,4-methylenedioxyphenoxymethyl)-1- methylpiperidine (1)

    03 (3s)-3-amino-1-t-butoxycarbonylmethyl-2,3,4,5-tetrahydro-1H-benzazepin-2-one (1)

    04 (5-methyl-2-oxo-1?3-dioxolen-4-yl) methyl 4-(1-hydroxy-1-methylethyl)-2-propyl-1-{4-[2-(trityltetrazol-5-yl)phenyl]phenyl} methylimidarde-5-carboxylate (1)

    05 (S)-1,2,3,4,-Tetrahydro-3-isoquinolinecarboxylic Acid, benzyl ester, p-toluenesulfonic acid salt (1)

    06 (S)-1,2,3,4,-Tetrahydro-3-isoquinolinecarboxylic acid (1)

    07 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1-triphenylmethyl-1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate (1)

    08 1-{2-cyanobiphenyl-4yl)methyl}-2-N-butyl-4-spirocyclopentane-2-imidazoli-5-one HCL ( hexane free) (1)

    09 2-Ethoxy-1-[[2'-(N-triphenylmethyltetrazol-5-yl)-biphenyl-4-yl]methyl]benzimidazole-7-carboxylic acid (1)

    10 2-butyl-4-chloro-1-[(2'-cyanobiphenyl-4-yl)methyl]-5-hydroxymethylimidazole (1)

    11 2-butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-Imidazole-5-methanol (1)

    12 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-benzimid azole-7-carboxylic acid (1)

    13 2-n-butyl-4-chloro-5-hydroxymethyl-1-[[2'(1H-2-triphenylmethyl-tetrazol-5-yl) biphenyl-4-yl]methyl]imidazole (1)

    14 3-Pyridinecarboxamide,2-chloro-N-(2-chloro-4-methyl-3-pyridinyl) (1)

    15 3Amino-2-chloro-4-methylpyridine (1)

    16 Endo,cis-2-azabicyclo[3,3,0]octane-3-carboxylic acid benzyl ester hydrochloride (1)

    17 Ethyl 2-ethoxy-1-[(2'-cyanobiphenyl-4-yl)-methyl]-1H- benzimidazole-7-carboxylate (1)

    18 Ethyl 4-(1-hydroxy-1-methylethyl)-2-propyl-imidazole-5-carboxylate (1)

    19 L-Valine methyl ester hydrochloride (1)

    20 Methyl 2-ethoxy-1-[(2'-cyanobiphenyl-4-yl)-methyl]-1H- benzimidazole-7-carboxylate (1)

    21 N-Triphenylmethyl-5-(4-bromomethylbiphenyl)-2-Tetrazole (1)

    22 N-[(2'-cyano[1,1'biphenyl]-4-yl)methyl]-methyl ester L-valine monohydrochloride (1)

    23 N-[1-(S)-ethoxycarbonyl-3-phenylpropyl]-L-alanine N-carboxyanhydride (1)

    24 N-[1-[(S)-ethoxycarbonyl-3-phenylpropyl]-L-alanine (1)

    25 N2-[(1s)-ethoxycarbonyl-3-phenylpropyl]-N6-trifluoroacetyl-L-lysine (1)

    26 [(2-methyl-1-propionylpropoxy)(4-phenylbutyl)phosphinoyl]acetic acid-cinchonidine (1)

    27 ethyl-4-(1-hydroxy-1-methylethyl)-2-propyl-1-{4-[2-(trityl tetrazol- 5-yl) phenyl]phenyl} methylimidazole-5-carboxylate (1)

    28 trans-4-(4-Fluorophenyl)-3-(hydroxymethyl)-1-methylpiperidine (1)

    29 trans-4-Cyclohexyl-L-proline (1)

    30 trans-4-Cyclohexyl-L-proline,hychochloride (1)

    filter

    01 Benazepril (1)

    02 Candesartan Cilexetil (5)

    03 Enalapril Maleate (2)

    04 Fosinopril (3)

    05 Irbesartan (1)

    06 Lisinopril (1)

    07 Losartan Potassium (4)

    08 Nevirapine (2)

    09 Olmesartan Medoxomil (3)

    10 Paroxetine Hydrochloride (3)

    11 Quinapril (2)

    12 Ramipril (1)

    13 Valsartan (2)

    filter

    01 103201-78-1 (1)

    02 103300-91-0 (1)

    03 105812-81-5 (1)

    04 109010-60-8 (1)

    05 109887-53-8 (1)

    06 110429-36-2 (1)

    07 114772-55-3 (1)

    08 114798-26-4 (1)

    09 124750-51-2 (1)

    10 124751-00-4 (1)

    11 133627-45-9 (1)

    12 133627-46-0 (1)

    13 137590-32-0 (1)

    14 138401-24-8 (1)

    15 139481-41-7 (1)

    16 139481-44-0 (1)

    17 139481-59-7 (1)

    18 139481-72-4 (1)

    19 144689-93-0 (1)

    20 144690-33-5 (1)

    21 144690-92-6 (1)

    22 170791-09-0 (1)

    23 482577-59-3 (1)

    24 6306-52-1 (1)

    25 74163-81-8 (1)

    26 77497-97-3 (1)

    27 82717-96-2 (1)

    28 84793-24-8 (1)

    29 90657-55-9 (1)

    30 93779-29-4 (1)

    ListList of Suppliers
    Contact SupplierContact Supplier
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    (3s)-3-amino-1-t-butoxycarbonylmethyl-2,3,4,5-tetrahydro-1H-be...

    PDF Supplier PDF
    URL Supplier Web Content
    109010-60-8
    Benazepril
    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was ...
    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai.
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    (3S,4R)-3-hydroxymethyl-4-(4'-fluorophenyl)-N-methylpiperidine

    PDF Supplier PDF
    URL Supplier Web Content
    105812-81-5
    Paroxetine Hydrochloride
    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was ...
    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai.
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    (3S,4R)-4-(4-fluorophenyl)-3-(3,4-methylenedioxyphenoxymethyl)...

    PDF Supplier PDF
    URL Supplier Web Content
    110429-36-2
    Paroxetine Hydrochloride
    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was ...
    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai.
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    (5-methyl-2-oxo-1?3-dioxolen-4-yl) methyl 4-(1-hydroxy-1-methy...

    PDF Supplier PDF
    URL Supplier Web Content
    144690-92-6
    Olmesartan Medoxomil
    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was ...
    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai.
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    (S)-1,2,3,4,-Tetrahydro-3-isoquinolinecarboxylic acid

    PDF Supplier PDF
    URL Supplier Web Content
    74163-81-8
    Quinapril
    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was ...
    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai.
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    (S)-1,2,3,4,-Tetrahydro-3-isoquinolinecarboxylic Acid, benzyl ...

    PDF Supplier PDF
    URL Supplier Web Content
    77497-97-3
    Quinapril
    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was ...
    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai.
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1-triphenyl...

    PDF Supplier PDF
    URL Supplier Web Content
    170791-09-0
    Candesartan Cilexetil
    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was ...
    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai.
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    1-{2-cyanobiphenyl-4yl)methyl}-2-N-butyl-4-spirocyclopentane-2...

    PDF Supplier PDF
    URL Supplier Web Content
    138401-24-8
    Irbesartan
    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was ...
    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai.
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    2-butyl-4-chloro-1-[(2'-cyanobiphenyl-4-yl)methyl]-5-hydroxyme...

    PDF Supplier PDF
    URL Supplier Web Content
    114772-55-3
    Losartan Potassium
    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was ...
    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai.
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    2-butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl...

    PDF Supplier PDF
    URL Supplier Web Content
    114798-26-4
    Losartan Potassium
    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was ...
    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai.
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Post Enquiry
    POST ENQUIRY